Initial screening of the primary patient tumours, PDXs and matched PDXOs for FGFR2 isoform status revealed similar patterns of FGFR2c splice isoform expression to that reported in a large clinical cohort of EC patients14. This evidence concerns the gene FGFR2 and neoplasm.